Dianthus Therapeutics, Inc. DNTH
84.55 USD -0.28 (-0.33%)
Regular-session close
84.10 -0.45 -0.53%
After hours · Nov 20, 7:42 PM ET
82.58 Day range 85.67
35.84 52-week range 117.88
- YTD
- +105.17%
- 1 year
- +109.33%
News
seekingalpha.com Dianthus Therapeutics, Inc. (DNTH) Presents at UBS Global Biopharma Conference 2026 Transcript Dianthus Therapeutics, Inc. (DNTH) Presents at UBS Global Biopharma Conference 2026 Transcript
defenseworld.net Dianthus Therapeutics (NASDAQ:DNTH) EVP Sells $9,118,555.02 in Stock Dianthus Therapeutics, Inc. (NASDAQ: DNTH - Get Free Report) EVP Ryan Savitz sold 100,713 shares of the business's stock in a transaction on Monday, November 9th. The shares were sold at an average…
benzinga.com This PPL Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday Analysts initiated Buy coverage on DRIO ($6), WATT ($15), PPL ($41), DNTH ($113); PYPD rated Outperform with a $10 target.benzinga.com Roth Capital Initiates Coverage On Dianthus Therapeutics with Buy Rating, Announces Price Target of $113 Roth Capital analyst Adam Walsh initiates coverage on Dianthus Therapeutics (NASDAQ:DNTH) with a Buy rating and announces Price Target of $113.
